HUAWEI WATCH D3 Bringing Advanced Blood Pressure Monitoring into Everyday Life

• 27 Oct 2026
• TM Team
• 0 Comments

The 31st International Society of Hypertension Scientific Meeting and 17th Emirates Cardiac Society Annual Conference (ISH-ECS 2026) took place in Dubai from 22 to 25 October 2026. As a major international gathering dedicated to hypertension, the conference brought together leading organisations and experts from around the world to discuss the latest research and developments in hypertension prevention and management.

International experts presented findings from their research using HUAWEI WATCH D Series wearable blood pressure monitors, highlighting the potential of wearable technology to support blood pressure monitoring and management. Huawei, a member of the International Society of Hypertension (ISH), also showcased its newly launched HUAWEI WATCH D3 at the event. At the Huawei exhibition area, attendees had the opportunity to experience the new device's medical-grade blood pressure monitoring capabilities across different scenarios first-hand, offering a closer look at how advanced wearable technology can make blood pressure monitoring more convenient and accessible in everyday life.

Hypertension is one of the most common chronic conditions worldwide and a leading risk factor for cardiovascular disease. Despite advances in prevention and treatment, blood pressure control rates remain low globally, highlighting the need for more effective monitoring and management.

To support further research in this field, Huawei has established the Wearable Blood Pressure Technology Innovation Fund in collaboration with ISH. The fund focuses on two key areas: wearable blood pressure measurement and wearable blood pressure management. It aims to encourage innovation, explore new applications for wearable technology, and support advances in hypertension prevention and management worldwide.

At the conference, researchers leading the first three projects selected for funding, from more than 80 applications, were invited to present their work. The projects involve researchers from the University of Colombo in Sri Lanka and the University of Edinburgh in the UK, Peking University People's Hospital in China, and the University of Cambridge in the UK. The funding will support further research into blood pressure management using HUAWEI WATCH D series devices.

As wearable health technology continues to advance, wrist-worn blood pressure monitors using inflatable cuffs and oscillometric measurement technology are gaining recognition within the international medical community.

These devices have been addressed in several international guidelines and expert consensus statements, including the European Society of Hypertension's Wearable Wrist-Watch Type Cuff Oscillometric Blood Pressure Monitors: Consensus Statement, the 2026 ISH Global Hypertension Practice Guidelines, and the HOPE Asia Network Asian Hypertension Guidelines. These publications recognise the potential role of validated wrist-worn oscillometric devices in blood pressure self-monitoring. Experts at the conference also discussed the significance of these developments and their implications for future clinical applications.

In China, the Chinese Guidelines for the Prevention and Management of Hypertension (2024 Edition) included wrist-worn oscillometric blood pressure monitoring for the first time. Meanwhile, the Expert Recommendations for Ambulatory Blood Pressure Measurement Using Wearable Devices recommended the use of smart wearable devices validated against international standards for ambulatory blood pressure monitoring. Together, these developments reflect growing international recognition of the role wearable technology can play in hypertension management.

During the "HUAWEI Wearable Technology" innovation and HUAWEI WATCH D3 experience sessions, HUAWEI experts introduced the technologies and applications behind the company's approach to comprehensive health management. International hypertension specialists also shared their perspectives on the HUAWEI WATCH D3 and its potential to make blood pressure monitoring more accessible.

Professor Wang Jiguang, President of the Chinese Hypertension Association, noted: "Innovations like Minimally Disruptive ABPM and environmental monitoring reminder by Huawei Watch D3 may be inspiring for shaping a new direction on how future blood pressure management is automated and seamlessly embedded into daily life, via wearable devices".

Professor George Stergiou, President of the International Society of Hypertension, described the Huawei Watch D3 as a novel, reliable wearable device that provides insights into blood pressure profiles and patterns. He also noted that the European Society of Hypertension (ESH) and the ISH encourages the clinical use of validated wrist-cuff blood pressure monitors, while calling for further research into their implementation in clinical practice.